Apple(US:AAPL) 智通财经网·2025-09-12 03:56Core Viewpoint - Apple has received FDA approval for its smartwatch's hypertension detection system, set to launch next week in 150 countries, including the US, Hong Kong, and the EU [1]. Group 1: Product Launch and Features - The hypertension detection tool will utilize data from the Apple Watch's optical heart rate sensor to analyze users' vascular responses over a 30-day period [1]. - Users will be notified of any signs of chronic hypertension and encouraged to inform healthcare professionals [1]. - The feature will be available on Apple Watch Series 9/10/11 and Ultra 2/3 models [1]. Group 2: Market Context and Competition - Apple is expanding its health product line amid increasing competition from other tech companies in the wearable health tracking space [2]. - Consumer hardware manufacturers are enhancing health tracking features in their devices, blurring the lines between wearables and medical devices [2]. - Whoop, a manufacturer of screenless smart bands, is resisting FDA's request to disable its blood pressure monitoring feature, which has not received the necessary certification [2]. Group 3: Health Statistics - Approximately 1.3 billion adults globally suffer from hypertension, a major risk factor for stroke, heart attacks, and kidney disease [1].